Prexion receives FDA approval for Eclipse 3D Cone Beam Computed Tomography Dental Scanner

Download PDF Copy

May 8 2013

The Eclipse 3D Cone Beam Computed Tomography (CBCT) Dental Scanner --Today, Prexion, Inc. announced FDA approval of the The Eclipse 3D Cone Beam Computed Tomography (CBCT) Dental Scanner.

"The exciting new 3D Eclipse highlights 2-in-1 and 3-in-1 multi-functionality, featuring dedicated 2D Digital Panoramic and Cephalometric options as well as maintaining industry leading CBCT 3D diagnostic clarity Prexion is famous for. The 3D Eclipse offers a new "Wide Mode" feature, enabling the clinician to capture full upper and lower dental arches, including the entire 3rd Molar region" said Takashi Funai , CEO at Prexion, Inc.

The Eclipse 3D Cone Beam Computed Tomography (CBCT) Dental Scanner Availability

The Eclipse 3D Cone Beam Computed Tomography (CBCT) Dental Scanner is a new product driven by customer feedback and is part of Prexion, Inc.'s commitment to deliver the highest 3D diagnostic clarity yet provide dedicated 2D digital radiographic and 3D CBCT modalities. The Eclipse 3D Cone Beam Computed Tomography (CBCT) Dental Scanner is available for demonstration at www.prexion.com or by calling 1-855-PREXION.

SOURCE Prexion, Inc.

Posted in: Device / Technology News | Healthcare News

Comments (0)

Download PDF Copy

Suggested Reading

Multi-fluid microRNA signals as markers of endometriosis

Artificial lung keeps patient alive after lung removal

Simple blood test maps hidden Alzheimer’s disease changes

Specific foods linked to autism risk via immune pathways

AI stethoscope doubles detection of serious valve disease in primary care study

Innovative light control technique improves miniature endoscopic imaging capabilities

Overlooked animal viruses slipping past global disease surveillance

Contextual errors limit real-world performance of medical AI

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.